Intel
INTC
Broadcom
AVGO
Alibaba
BABA
NVIDIA
NVDA
Micron Technology
MU
US Stock MarketDetailed Quotes
MNOV MediciNova
- 1.830
- -0.040-2.14%
Close Jan 17 16:00 ET
89.75MMarket Cap-8.71P/E (TTM)
1.960High1.830Low24.90KVolume1.960Open1.870Pre Close47.22KTurnover0.06%Turnover RatioLossP/E (Static)49.05MShares2.55052wk High1.63P/B77.01MFloat Cap1.12052wk Low--Dividend TTM42.08MShs Float16.120Historical High--Div YieldTTM6.95%Amplitude1.120Historical Low1.896Avg Price1Lot Size
MediciNova News
MediciNova Presents Study Update And Interim Analysis Of Phase 2/3 Clinical Trial Of MN-166 In ALS At The 35th International Symposium On ALS/MND
Express News | MediciNova Inc - Expects to Complete Patient Assignments by June 2025 With Trial Results Expected in 2026
Express News | MediciNova Inc - Positive Correlations Observed Between 6-Month and 12-Month Data
Express News | Medicinova Presents Study Update and Interim Analysis of Phase 2/3 Clinical Trial of Mn-166 (Ibudilast) in ALS (Combat-ALS Clinical Trial) at the 35TH International Symposium on ALS/Mnd
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
D. Boral Capital Initiates MediciNova(MNOV.US) With Buy Rating, Announces Target Price $9
D. Boral Capital Initiates Coverage On MediciNova With Buy Rating, Announces Price Target of $9
MediciNova Analyst Ratings
MediciNova Highlights Strategic Focus On Non-Dilutive Funding With NIH-Funded ALS Trial And Canadian Long COVID Study, Reports Strong $42.3M Cash Position, And Reaffirms Commitment To Sustainable Growth And Shareholder Transparency
MediciNova Provides Update in Letter to Stockholders
Express News | Medicinova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders
MediciNova Granted Notice of Allowance for MN-001 Patent by USPTO
Express News | MediciNova Receives Notice Of Allowance From US PTO For A Pending Patent Application For MN-001 (Tipelukast) To Cover 'Method To Decrease Triglyceride Synthesis In A Liver Of A Subject'
Express News | MediciNova Inc - Patent Is Expected to Expire No Earlier Than May 26, 2042
Express News | Medicinova Receives Notice of Allowance From United States Patent and Trademark Office for New Patent Covering Mn-001 for Triglyceride Synthesis in the Liver
MediciNova | 10-Q: Q3 2024 Earnings Report
MediciNova: Q3 Earnings Snapshot
MediciNova MNOV Settlement; Neurogene NGNE Discontinuation
Express News | MediciNova Shares Are Trading Higher After the Company Announced That It Was Notified by Sanofi That the Sanofi/Novartis Litigation Was Settled
Express News | MediciNova Says Notified By Sanofi That Sanofi/Novartis Litigation Was Settled; Says It Is Entitled To Receive Certain Amount Of Monetary Damages Through This Settlement
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.